Cleared Traditional

K935666 - PERKIN-ELMER SERIES 200 LIQ CHROMATOGRAPHIC PUMP (FDA 510(k) Clearance)

Class I Toxicology device.

K935666 · The Perkin-Elmer Corp. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
151d
Days
Class 1
Risk

K935666 is an FDA 510(k) clearance for the PERKIN-ELMER SERIES 200 LIQ CHROMATOGRAPHIC PUMP. Classified as Apparatus, High Pressure Liquid Chromatography (product code KIE), Class I - General Controls.

Submitted by The Perkin-Elmer Corp. (Norwalk, US). The FDA issued a Cleared decision on April 26, 1994 after a review of 151 days - an extended review cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.2260 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all The Perkin-Elmer Corp. devices

Submission Details

510(k) Number K935666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 1993
Decision Date April 26, 1994
Days to Decision 151 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
64d slower than avg
Panel avg: 87d · This submission: 151d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KIE Apparatus, High Pressure Liquid Chromatography
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.2260
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.